These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9296258)

  • 1. Comment: cost comparison of recombinant human erythropoietin and blood transfusion in cancer chemotherapy-induced anemia.
    Finkelstein SN; Huber SL; Greenberg PE
    Ann Pharmacother; 1997 Sep; 31(9):1094-5. PubMed ID: 9296258
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost comparison of recombinant human erythropoietin and blood transfusion in cancer chemotherapy-induced anemia.
    Sheffield R; Sullivan SD; Saltiel E; Nishimura L
    Ann Pharmacother; 1997 Jan; 31(1):15-22. PubMed ID: 8997459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant erythropoietin and blood transfusions in cancer chemotherapy-induced anemia.
    Griggs JJ; Blumberg N
    Anticancer Drugs; 1998 Nov; 9(10):925-32. PubMed ID: 9890704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of recombinant human erythropoietin versus transfusions in the treatment of zidovudine-related anemia in HIV-infected children.
    Allen UD; Kirby MA; Goeree R
    Pediatr AIDS HIV Infect; 1997 Feb; 8(1):4-11. PubMed ID: 11361510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer- and chemotherapy-induced anemia.
    Rodgers GM; Becker PS; Bennett CL; Cella D; Chanan-Khan A; Chesney C; Cleeland C; Coccia PF; Djulbegovic B; Garst JL; Gilreath JA; Kraut EH; Lin WC; Matulonis U; Millenson M; Reinke D; Rosenthal J; Sabbatini P; Schwartz RN; Stein RS; Vij R;
    J Natl Compr Canc Netw; 2008 Jul; 6(6):536-64. PubMed ID: 18597709
    [No Abstract]   [Full Text] [Related]  

  • 6. Anemia therapy: individual benefit and societal cost.
    Denton TA; Diamond GA; Matloff JM; Gray RJ
    Semin Oncol; 1994 Apr; 21(2 Suppl 3):29-35. PubMed ID: 8202723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of erythropoietin in the treatment of cancer-related anemia].
    Huang JX; Meng FJ
    Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):877-8. PubMed ID: 22335959
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of anemia in Patient Blood Management from an economic perspective].
    Bisbe Vives E
    Rev Esp Anestesiol Reanim; 2015 Jun; 62 Suppl 1():80-5. PubMed ID: 26320350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of cancer anemia.
    Henry DH
    Support Care Cancer; 1994 Nov; 2(6):403-4. PubMed ID: 7858936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Routine once-weekly darbepoetin alfa administration is cost-effective in lung cancer patients with chemotherapy-induced anemia: a Markov analysis.
    Borget I; Tilleul P; Baud M; Joly AC; Daguenel A; Chouaid C
    Lung Cancer; 2006 Mar; 51(3):369-76. PubMed ID: 16388876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits and costs of recombinant human erythropoietin for end-stage renal failure: a review. Benefits and costs of erythropoietin.
    McNamee P; van Doorslaer E; Segaar R
    Int J Technol Assess Health Care; 1993; 9(4):490-504. PubMed ID: 8288425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia.
    Barosi G; Marchetti M; Liberato NL
    Br J Cancer; 1998 Sep; 78(6):781-7. PubMed ID: 9743301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Questionable conclusions about epoetin alfa.
    Kruse MW; Lee JJ
    Am J Health Syst Pharm; 2007 Sep; 64(17):1789-90; author reply 1790-1. PubMed ID: 17724355
    [No Abstract]   [Full Text] [Related]  

  • 14. Controlled multicentre study of the influence of subcutaneous recombinant human erythropoietin on anaemia and transfusion dependency in patients with ovarian carcinoma treated with platinum-based chemotherapy.
    ten Bokkel Huinink WW; de Swart CA; van Toorn DW; Morack G; Breed WP; Hillen HF; van der Hoeven JJ; Reed NS; Fairlamb DJ; Chan SY; Godfrey KA; Kristensen GB; van Tinteren H; Ehmer B
    Med Oncol; 1998 Sep; 15(3):174-82. PubMed ID: 9819794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comment: Epoetin alfa versus darbepoetin alfa for cancer patients with treatment-related anemia.
    Yang MC
    Ann Pharmacother; 2006 May; 40(5):998-9; author reply 999. PubMed ID: 16670351
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of the efficacy of two dosages and schedules of human recombinant erythropoietin in the prevention and correction of cisplatin-induced anemia in cancer patients.
    Mantovani G; Ghiani M; Curreli L; Maccio A; Massa D; Succu G; Lai P; Massa E; Mudu MC; Astara G
    Oncol Rep; 1999; 6(2):421-6. PubMed ID: 10023014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the use of recombinant human erythropoietin in anaemia of prematurity cost-effective?
    Meyer MP; Haworth C; McNeill L
    S Afr Med J; 1996 Mar; 86(3):251-3. PubMed ID: 8658295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietic therapy for the treatment of anemia in patients with cancer: a valuable clinical and economic option.
    Cornes P; Coiffier B; Zambrowski JJ
    Curr Med Res Opin; 2007 Feb; 23(2):357-68. PubMed ID: 17288690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin therapy for premature infants: cost without benefit?
    Zipursky A
    Pediatr Res; 2000 Aug; 48(2):136. PubMed ID: 10926284
    [No Abstract]   [Full Text] [Related]  

  • 20. Erythropoietin in the management of patients with nonhematologic cancer receiving chemotherapy. Systemic Treatment Program Committee.
    Quirt I; Micucci S; Moran LA; Pater J; Browman G
    Cancer Prev Control; 1997 Aug; 1(3):241-8. PubMed ID: 9765749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.